Overall rank by patents
#30,395
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 5 technology areas, active 2016–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B29L (INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES).
The verdict
The holds 9 US patents across 5 technology areas, rank #30,395 of 50,000 tracked assignees.
The Monte Vista Group, Llc has been granted 9 US utility patents between 2016 and 2023, placing The Monte Vista Group, Llc at rank #30,395 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 1.4 claims per patent with primary concentration in B29L (INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES). As a US Corporation, The Monte Vista Group, Llc is one of the more focused assignees in the PatentsView dataset. By volume, The sits between The Government Of The United States Of American, As Represented By The Secretary, Department Of Health And Human Services (9 patents, rank #30,391) and The Privacy Factor, Llc (9 patents, rank #30,399) - the closest US assignees by grant volume. The composite Innovation Score of 36.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 8 grants, compared with 1 in the 2015–2019 window, a +700% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. The Monte Vista Group, Llc's 1.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark The Monte Vista Group, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services
9 patents
The Intellisis Corporation
9 patents
The Japan Research Institute, Limited
9 patents
The Marco Company
9 patents
The NORDAM Group LLC
9 patents
The Neat Company, Inc.
9 patents
The Oilgear Company
9 patents
The Privacy Factor, LLC
9 patents
The Monte Vista Group, LLC
9 patents
What this shows The holds 9 patents at rank #30,395, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #30,395 in granted patent volume.
Other assignees with the most granted patents in The's primary technology class.
The's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
37 Top 46% higher than 54% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 11.1% |
| 2023 | 8 | 88.9% |
Top 5 of 5 technology areas
Overall rank by patents
#30,395
Across all tracked assignees
36.7 out of 100
How to use this portfolio
The's 9 grants land it in the top 46% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.